ANGO vs NVST · rev $292.5M vs P/E 56, rev $2.51B
AngioDynamics Inc (ANGO) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported NVST revenue for 2024-12-31 was $2.51B. Net income was -$1.12B. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
ANGO currently screens at market cap $378.5M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the ANGO and NVST stock pages for the full models.
Not investment advice.